BioNexus Gene Lab Corp - Common stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 14/08/2026 | Mar 2026Filed 14/08/2026 | Sep 2025Filed 14/11/2025 | Jun 2025Filed 14/08/2026 | Mar 2025Filed 14/08/2026 | Sep 2024Filed 14/11/2025 | Jun 2024Filed 18/08/2025 | Mar 2024Filed 15/05/2025 |
|---|---|---|---|---|---|---|---|---|
| $0.1 | $0 | $2.5 | $2.3 | $2.1 | $2.6 | $2 | $2.4 | |
| −$0.3 | −$0.5 | −$0.7 | −$0.6 | −$0.6 | −$1.3 | $0.2 | −$0.1 | |
| −$0.12 | −$0.23 | −$0.40 | −$0.34 | −$0.35 | −$0.75 | $0.11 | −$0.01 | |
| 2.4 | 2.4 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 18 |
Trend